Marina Biotech Inc. (MRNA)
  • Россия
  • Украина

Marina Biotech Inc. (MRNA)

Contact Details

Bothell, Washington 98041, USA
(425) 892-4322
Bothell, Washington 98041, USA

General Information

Marina Biotech, Inc., formerly known as MDRNA, Inc., is a biotechnology company, focused on the development and commercialization of therapeutic products based on RNA interference (RNAi). The Company`s pipeline currently includes a clinical program in Familial Adenomatous Polyposis (a precancerous syndrome) and two preclinical programs in hepatocellular carcinoma and bladder cancer. Marina`s goal is to improve human health through the development of RNAi-based compounds and drug delivery technologies that together provide superior therapeutic options for patients. Marina Biotech, Inc. is headquartered in Bothell, Washington.

Contact Information

Phone(425) 892-4322
Thomson Reuters PermID4295907254


NamePositionTotal Annual CompensationYearPercent Change in Compensation
Former CFO and Former Secretary$1,049,404200995.6%
Former Other Executive Officer$949,234200862.2%
Former President$830,492200864.7%
Former CFO$589,4492007-2.1%
Chief Scientific Officer and Divisional Senior VP$550,366200619.4%
CEO, Director and President$503,0822010-32.1%
Divisional Former Senior VP$481,3762007-8.4%
Other Corporate Officer$308,698200725.2%
Chief Scientific Officer$306,2482010-51.2%
Director and Chairman of the Board$170,662200811.7%

Government Contracts

Largest Contracts

AgencyProduct or ServiceSigned DateObligation Amount
National Aeronautics and Space AdministrationDrugs and BiologicalsApril 08, 2004$55,000

Corporate Data


  • Pharmaceutical Preparation Manufacturing

SIC Industries

  • Pharmaceutical Preparations

Company Size

Sales Volume$500,000


Ticker SymbolMRNA
ExchangeOTC Bulletin Board Pink Sheets (PK)
Year Founded1983


52-Week Range0.12 - 0.64
Average Volume (1M)69,409
Market Cap.$4.1 Million
Last Dividend Amount0


Summary of Form-D Filings

    Filing History

  • Marina Biotech, Inc. has filed 1 Form Ds since 2008. Of these filings, 1 has been for a unique offering.
  • Through these filings, they have raised $6,000,000.
  • They have not paid finder`s fees or sales commissions in connection with these offerings.
  • They have not used any of the proceeds from its offerings to pay officers or directors.
  • The types of securities they have issued are Equity and Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security.
  • They have relied on the following exemptions in past filings Rule 506(b).

    Analysis of Past Filings

  • Marina Biotech, Inc. has filed 1 fewer filing compared to an average company in the Biotechnology category.
  • They have had about as many unique offerings as an average company in the Biotechnology category.
  • The total amount raised they have raised is 91% higher than the average for a company in the Biotechnology category.


Period EndingDec. 31, 2015Sep. 30, 2015Jun. 30, 2015Mar. 31, 2015
Total Revenue20080400-
Cost of Revenue----
Gross Profit20080400-
Research Development22790230254
Selling General and Administrative5931,0221,1921,061
Depreciation and Amortization----
Other Operating Expenses----
Total Operating Expenses8201,1121,4221,315
Other Income/Expenses Net----
Earnings Before Interest and Taxes(620)(1,032)(1,022)(1,315)
Interest Expense----
Income Before Tax5601,459904414
Income Tax Expense----
Minority Interest----
Net Income from Continuing Ops5601,459904414
Discontinued Operations----
Extraordinary Items----
Effect of Accounting Changes----
Other Items----
Net Income5601,459904414
Preferred Stock and Other Adjustments-690--
Net Income Applicable to Common Shares560769904414